HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anthony Y Smith Selected Research

Testosterone (Sustanon)

12/2008The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anthony Y Smith Research Topics

Disease

9Prostatic Neoplasms (Prostate Cancer)
08/2012 - 02/2005
7Neoplasms (Cancer)
08/2012 - 02/2005
2Margins of Excision
08/2012 - 09/2011
2Adenocarcinoma
09/2011 - 02/2005
2Carcinogenesis
12/2008 - 02/2005
1Prostatic Intraepithelial Neoplasia
09/2010
1Disease Progression
12/2008
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
02/2005

Drug/Important Bio-Agent (IBA)

4Prostate-Specific Antigen (Semenogelase)IBA
05/2011 - 02/2005
3DNA (Deoxyribonucleic Acid)IBA
09/2010 - 02/2005
2EnzymesIBA
08/2012 - 12/2008
2Citric Acid (Citrate)FDA LinkGeneric
11/2006 - 02/2005
1Fatty Acid Synthases (Fatty Acid Synthase)IBA
08/2012
1Messenger RNA (mRNA)IBA
08/2012
1Transcription Factors (Transcription Factor)IBA
08/2012
1Biomarkers (Surrogate Marker)IBA
05/2011
1SteroidsIBA
12/2008
1Dihydrotestosterone (Androstanolone)IBA
12/2008
1AndrogensIBA
12/2008
1Testosterone (Sustanon)FDA Link
12/2008
1ParaffinIBA
02/2005

Therapy/Procedure

4Prostatectomy (Retropubic Prostatectomy)
08/2012 - 02/2005
2Therapeutics
09/2011 - 09/2010
1Chemoprevention
05/2011
1Massage (Zone Therapy)
02/2005